What is the current annual net income of GSK?

As of today, GSK annual net income is $8.29B

What is 1-year change in GSK annual net income?

GSK annual net income is up +119.80% year-over-year

What is 3-year change in GSK annual net income?

GSK annual net income is up +36.73% over the past 3 years

How far is GSK annual net income from its all-time high?

GSK annual net income is currently -35.20% below its historical high of $12.79B set on December 31, 2015

How does GSK annual net income rank versus sector peers?

GSK annual net income is higher than 99.29% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 3, 2027

What is the current quarterly net income of GSK?

As of today, GSK quarterly net income is $2.29B

What is GSK quarterly net income most recent change?

GSK quarterly net income was up +208.36% on September 30, 2026

What is 1-year change in GSK quarterly net income?

GSK quarterly net income is down -20.84% year-over-year

How far is GSK quarterly net income from its all-time high?

GSK quarterly net income is currently -81.15% below its historical high of $12.14B set on March 31, 2015

How does GSK quarterly net income rank versus sector peers?

GSK quarterly net income is higher than 99.15% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

What is the current TTM net income of GSK?

As of today, GSK TTM net income is $6.48B

What is GSK TTM net income most recent change?

GSK TTM net income was down -8.51% on September 30, 2026

What is 1-year change in GSK TTM net income?

GSK TTM net income is down -18.67% year-over-year

How far is GSK TTM net income from its all-time high?

GSK TTM net income is currently -58.46% below its historical high of $15.59B set on March 31, 2015

How does GSK TTM net income rank versus sector peers?

GSK TTM net income is higher than 98.87% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

GSK Plc (GSK) Net Income History & Chart Since 1985

Annual Net Income

$8.29B$4.52B+119.80%

December 31, 2025

Summary

Current Value: As of today, GSK annual net income is $8.29B, up +119.80% on December 31, 2025
Historical Performance: GSK annual net income is up +36.73% over the past 3 years, up +1.18% over the past 5 years
All-Time High Comparison: GSK annual net income is currently -35.20% below its historical high of $12.79B set on December 31, 2015
3-Year Low Comparison: GSK annual net income is +119.80% above its 3-year low of $3.77B reached on December 31, 2024
Sector Comparison: GSK annual net income is higher than 99.29% of companies in Healthcare sector

Net Income Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Net Income	Dec 31, 25	$8.29B	+119.8%	+36.7%	+1.2%	+189.8%
Quarterly Net Income	Sep 30, 26	$2.29B	-20.8%	+17.9%	+75.6%	-1.4%
TTM Net Income	Sep 30, 26	$6.48B	-18.7%	-19.2%	+9.3%	+12.9%
Price	Nov 2, 26	$49.13	+4.8%	+43.8%	+12.6%	+11.4%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%
PE Ratio	Nov 2, 26	17.13	+28.1%	+82.4%	+15.3%	+2.2%
Annual EPS	Dec 31, 25	$3.66	+130.3%	-59.4%	+0.0%	+197.3%
Annual Operating Profit	Dec 31, 25	$9.45B	+30.6%	+14.8%	-10.0%	+22.9%

Net Income Highs

GSK Annual Net Income Highs Comparison
Period	High	Date	Current
3Y	$8.29B	Dec 31, 25	at high
5Y	$8.29B	Dec 31, 25	at high
All	$12.79B	Dec 31, 15	-35.2%

Net Income Lows

GSK Annual Net Income Lows Comparison
Period	Low	Date	Current
3Y	$3.77B	Dec 31, 24	+119.8%
5Y	$3.77B	Dec 31, 24	+119.8%
All	$576.08M	Jun 30, 86	+1338.7%

Net Income History

Year	Value	Change
2025	$8.29B	+119.8%
2024	$3.77B	-42.9%
2023	$6.60B	+8.9%
2022	$6.06B	+25.4%
2021	$4.84B	-41.0%
2020	$8.19B	+21.9%
2019	$6.72B	+24.6%
2018	$5.39B	+93.1%
2017	$2.79B	+95.4%
2016	$1.43B	-88.8%
2015	$12.79B	+174.4%
2014	$4.66B	-47.1%
2013	$8.81B	+18.9%
2012	$7.41B	-15.3%
2011	$8.75B	+205.9%
2010	$2.86B	-67.9%
2009	$8.90B	+2.6%
2008	$8.67B	-18.4%
2007	$10.63B	+5.0%
2006	$10.12B	+15.6%

Year	Value	Change
2005	$8.75B	+18.8%
2004	$7.37B	-1.8%
2003	$7.50B	+23.5%
2002	$6.07B	+32.2%
2001	$4.59B	-29.9%
2000	$6.55B	+34.2%
1999	$4.88B	+58.7%
1998	$3.08B	+0.6%
1997	$3.06B	-3.5%
1996	$3.17B	+98.1%
1995	$1.60B	-18.5%
1994	$1.96B	+0.5%
1993	$1.95B	+6.7%
1992	$1.83B	+7.0%
1991	$1.71B	+30.2%
1990	$1.31B	+11.2%
1989	$1.18B	+15.9%
1988	$1.02B	+31.0%
1987	$777.81M	+35.0%
1986	$576.08M	-

FAQ

What is the current annual net income of GSK?: As of today, GSK annual net income is $8.29B
What is 1-year change in GSK annual net income?: GSK annual net income is up +119.80% year-over-year
What is 3-year change in GSK annual net income?: GSK annual net income is up +36.73% over the past 3 years
How far is GSK annual net income from its all-time high?: GSK annual net income is currently -35.20% below its historical high of $12.79B set on December 31, 2015
How does GSK annual net income rank versus sector peers?: GSK annual net income is higher than 99.29% of companies in Healthcare sector
When is GSK next annual earnings release?: The next annual earnings release for GSK is on February 3, 2027

Net Income Formula

Net Income = Revenue − Cost Of Goods Sold − Operating Expenses − Interest Expense − Income Tax − Other Expenses

Quarterly Net Income

$2.29B$1.55B+208.36%

September 30, 2026

Summary

Current Value: As of today, GSK quarterly net income is $2.29B, up +208.36% on September 30, 2026
Historical Performance: GSK quarterly net income is down -20.84% year-over-year, up +17.91% over the past 3 years
All-Time High Comparison: GSK quarterly net income is currently -81.15% below its historical high of $12.14B set on March 31, 2015
3-Year Low Comparison: GSK quarterly net income is +2608.64% above its 3-year low of $84.50M reached on September 30, 2024
Sector Comparison: GSK quarterly net income is higher than 99.15% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Net Income	Sep 30, 26	$2.29B	+208.4%	-20.8%	+17.9%	+75.6%
Annual Net Income	Dec 31, 25	$8.29B	–	+119.8%	+36.7%	+1.2%
TTM Net Income	Sep 30, 26	$6.48B	-8.5%	-18.7%	-19.2%	+9.3%
Price	Nov 2, 26	$49.13	-5.0%	+4.8%	+43.8%	+12.6%
Quarterly Revenue	Sep 30, 26	$11.94B	+5.8%	+3.6%	+15.8%	+30.8%
PE Ratio	Nov 2, 26	17.13	+5.2%	+28.1%	+82.4%	+15.3%
Quarterly EPS	Sep 30, 26	$1.02	+254.2%	-23.1%	+13.0%	+28.3%
Quarterly Operating Profit	Sep 30, 26	$3.45B	+7.3%	-0.4%	+21.6%	+55.4%

Quarterly Net Income Highs

GSK Quarterly Net Income Highs Comparison
Period	High	Date	Current
1Y	$2.89B	N/A	-20.8%
3Y	$2.89B	Sep 30, 25	-20.8%
5Y	$2.89B	Sep 30, 25	-20.8%
All	$12.14B	Mar 31, 15	-81.2%

Quarterly Net Income Lows

GSK Quarterly Net Income Lows Comparison
Period	Low	Date	Current
1Y	$742.26M	Jun 30, 26	+208.4%
3Y	$84.50M	Sep 30, 24	+2608.6%
5Y	$84.50M	Sep 30, 24	+2608.6%
All	-$996.30M	Dec 31, 10	+329.7%

Quarterly Net Income History

Month	Value	Change
Sep 2026	$2.29B	+208.4%
Jun 2026	$742.26M	-70.0%
Mar 2026	$2.48B	+156.3%
Dec 2025	$966.83M	-66.6%
Sep 2025	$2.89B	+31.6%
Jun 2025	$2.20B	-1.5%
Mar 2025	$2.23B	+247.5%
Dec 2024	$642.07M	+659.8%
Sep 2024	$84.50M	-94.9%
Jun 2024	$1.65B	+20.0%
Mar 2024	$1.37B	+177.6%
Dec 2023	$493.76M	-74.6%
Sep 2023	$1.94B	-11.1%
Jun 2023	$2.18B	+10.2%
Mar 2023	$1.98B	+4.0%
Dec 2022	$1.91B	+108.0%
Sep 2022	$916.24M	-2.1%
Jun 2022	$935.73M	-60.6%
Mar 2022	$2.37B	+319.6%
Dec 2021	$566.05M	-56.6%
Sep 2021	$1.30B	-26.6%
Jun 2021	$1.78B	+2.3%
Mar 2021	$1.74B	+56.8%
Dec 2020	$1.11B	-40.0%
Sep 2020	$1.85B	-39.0%
Jun 2020	$3.03B	+41.2%
Mar 2020	$2.15B	+9.9%
Dec 2019	$1.95B	-7.7%
Sep 2019	$2.12B	+56.7%
Jun 2019	$1.35B	+5.2%
Mar 2019	$1.28B	-23.3%
Dec 2018	$1.67B	-15.1%
Sep 2018	$1.97B	+205.1%
Jun 2018	$645.75M	-38.9%
Mar 2018	$1.06B	+319.3%
Dec 2017	-$481.58M	-126.4%
Sep 2017	$1.82B	+1,757.4%
Jun 2017	-$110.11M	-107.3%
Mar 2017	$1.52B	+287.0%
Dec 2016	$391.60M	-66.3%
Sep 2016	$1.16B	+266.3%
Jun 2016	-$698.18M	-240.0%
Mar 2016	$498.60M	+176.8%
Dec 2015	-$649.11M	-165.2%
Sep 2015	$994.92M	+459.9%
Jun 2015	$177.69M	-98.5%
Mar 2015	$12.14B	+648.3%
Dec 2014	$1.62B	+154.4%
Sep 2014	$637.84M	-46.3%
Jun 2014	$1.19B	-0.6%
Mar 2014	$1.20B	-70.8%
Dec 2013	$4.09B	+161.4%
Sep 2013	$1.57B	-5.9%
Jun 2013	$1.66B	+4.3%
Mar 2013	$1.60B	+20.7%
Dec 2012	$1.32B	-29.0%
Sep 2012	$1.86B	-9.7%
Jun 2012	$2.06B	-4.4%
Mar 2012	$2.16B	+6.3%
Dec 2011	$2.03B	-12.6%
Sep 2011	$2.32B	+24.2%
Jun 2011	$1.87B	-26.3%
Mar 2011	$2.54B	+354.7%
Dec 2010	-$996.30M	-147.6%
Sep 2010	$2.09B	+656.6%
Jun 2010	-$376.29M	-117.4%
Mar 2010	$2.16B	-20.8%
Dec 2009	$2.73B	+21.3%
Sep 2009	$2.25B	-2.6%
Jun 2009	$2.31B	+37.8%
Mar 2009	$1.68B	+7.7%
Dec 2008	$1.56B	-20.9%
Sep 2008	$1.97B	-24.1%
Jun 2008	$2.59B	-2.2%
Mar 2008	$2.65B	+20.4%
Dec 2007	$2.20B	-19.1%
Sep 2007	$2.72B	+1.1%
Jun 2007	$2.69B	-10.2%
Mar 2007	$3.00B	+29.9%
Dec 2006	$2.31B	-13.7%
Sep 2006	$2.67B	+9.4%
Jun 2006	$2.44B	-8.8%

Month	Value	Change
Mar 2006	$2.68B	+33.3%
Dec 2005	$2.01B	-10.1%
Sep 2005	$2.24B	+1.4%
Jun 2005	$2.21B	-4.6%
Mar 2005	$2.31B	+54.8%
Dec 2004	$1.49B	-21.2%
Sep 2004	$1.89B	-5.9%
Jun 2004	$2.01B	+3.3%
Mar 2004	$1.95B	+40.3%
Dec 2003	$1.39B	-28.3%
Sep 2003	$1.94B	-11.7%
Jun 2003	$2.19B	+12.3%
Mar 2003	$1.95B	+27.9%
Dec 2002	$1.53B	+20.0%
Sep 2002	$1.27B	-27.7%
Jun 2002	$1.76B	+17.4%
Mar 2002	$1.50B	+2.5%
Dec 2001	$1.46B	+152.2%
Sep 2001	$579.05M	-61.2%
Jun 2001	$1.49B	+41.4%
Mar 2001	$1.06B	-58.1%
Dec 2000	$2.52B	+128.0%
Sep 2000	$1.11B	-17.9%
Jun 2000	$1.35B	+5.7%
Mar 2000	$1.27B	+70.1%
Dec 1999	$748.61M	+1.9%
Sep 1999	$734.58M	-4.5%
Jun 1999	$769.18M	+3.1%
Mar 1999	$746.03M	-12.0%
Dec 1998	$847.33M	+1.7%
Sep 1998	$833.18M	+21.9%
Jun 1998	$683.47M	+0.5%
Mar 1998	$680.26M	+7.8%
Dec 1997	$631.02M	-7.1%
Sep 1997	$678.89M	-18.9%
Jun 1997	$836.67M	-1.4%
Mar 1997	$848.90M	-38.8%
Dec 1996	$1.39B	+664.6%
Sep 1996	$181.27M	-77.2%
Jun 1996	$794.63M	-2.1%
Mar 1996	$811.76M	+97.4%
Sep 1995	$411.31M	-4.8%
Jun 1995	$431.87M	+6.5%
Mar 1995	$405.61M	-3.3%
Dec 1994	$419.37M	+3.3%
Sep 1994	$405.93M	+1.7%
Jun 1994	$399.24M	-15.4%
Mar 1994	$471.74M	-12.3%
Dec 1993	$537.98M	+1.3%
Sep 1993	$531.29M	+35.4%
Jun 1993	$392.26M	-25.6%
Mar 1993	$526.93M	+14.0%
Dec 1992	$462.18M	-2.9%
Sep 1992	$475.77M	+41.8%
Jun 1992	$335.55M	-32.9%
Mar 1992	$499.82M	+7.2%
Dec 1991	$466.37M	-1.3%
Sep 1991	$472.50M	-3.0%
Jun 1991	$487.06M	+19.9%
Mar 1991	$406.21M	+8.7%
Dec 1990	$373.54M	+1.5%
Sep 1990	$367.88M	+9.8%
Jun 1990	$334.99M	-7.8%
Mar 1990	$363.21M	+10.4%
Dec 1989	$328.94M	+0.5%
Sep 1989	$327.45M	-1.5%
Jun 1989	$332.29M	+29.5%
Mar 1989	$256.54M	-10.0%
Dec 1988	$284.94M	-1.1%
Sep 1988	$288.18M	-11.6%
Jun 1988	$325.99M	+43.7%
Mar 1988	$226.85M	-4.8%
Dec 1987	$238.18M	-5.5%
Sep 1987	$252.17M	+9.7%
Jun 1987	$229.83M	+7.7%
Mar 1987	$213.41M	+23.6%
Dec 1986	$172.64M	-6.0%
Sep 1986	$183.63M	+39.6%
Jun 1986	$131.55M	-13.4%
Mar 1986	$151.84M	-1.1%
Dec 1985	$153.54M	+1.4%
Sep 1985	$151.39M	-

FAQ

What is the current quarterly net income of GSK?: As of today, GSK quarterly net income is $2.29B
What is GSK quarterly net income most recent change?: GSK quarterly net income was up +208.36% on September 30, 2026
What is 1-year change in GSK quarterly net income?: GSK quarterly net income is down -20.84% year-over-year
How far is GSK quarterly net income from its all-time high?: GSK quarterly net income is currently -81.15% below its historical high of $12.14B set on March 31, 2015
How does GSK quarterly net income rank versus sector peers?: GSK quarterly net income is higher than 99.15% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Net Income Formula

Net Income = Revenue − Cost Of Goods Sold − Operating Expenses − Interest Expense − Income Tax − Other Expenses

TTM Net Income

$6.48B$602.66M-8.51%

September 30, 2026

Summary

Current Value: As of today, GSK TTM net income is $6.48B, down -8.51% on September 30, 2026
Historical Performance: GSK TTM net income is down -18.67% year-over-year, down -19.19% over the past 3 years
All-Time High Comparison: GSK TTM net income is currently -58.46% below its historical high of $15.59B set on March 31, 2015
3-Year Low Comparison: GSK TTM net income is +80.17% above its 3-year low of $3.59B reached on September 30, 2024
Sector Comparison: GSK TTM net income is higher than 98.87% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Net Income	Sep 30, 26	$6.48B	-8.5%	-18.7%	-19.2%	+9.3%
Annual Net Income	Dec 31, 25	$8.29B	–	+119.8%	+36.7%	+1.2%
Quarterly Net Income	Sep 30, 26	$2.29B	+208.4%	-20.8%	+17.9%	+75.6%
Price	Nov 2, 26	$49.13	-5.0%	+4.8%	+43.8%	+12.6%
TTM Revenue	Sep 30, 26	$44.97B	+0.9%	+6.9%	+23.6%	+15.1%
PE Ratio	Nov 2, 26	17.13	+5.2%	+28.1%	+82.4%	+15.3%
TTM EPS	Sep 30, 26	$2.87	-9.6%	-18.2%	-21.1%	-2.3%
TTM Operating Profit	Sep 30, 26	$11.12B	-0.1%	+6.4%	+35.9%	+36.6%

TTM Net Income Highs

GSK TTM Net Income Highs Comparison
Period	High	Date	Current
1Y	$8.53B	Mar 31, 26	-24.1%
3Y	$8.53B	Mar 31, 26	-24.1%
5Y	$8.53B	Mar 31, 26	-24.1%
All	$15.59B	Mar 31, 15	-58.5%

TTM Net Income Lows

GSK TTM Net Income Lows Comparison
Period	Low	Date	Current
1Y	$6.48B	Sep 30, 26	at low
3Y	$3.59B	Sep 30, 24	+80.2%
5Y	$3.59B	Sep 30, 24	+80.2%
All	$146.23M	Jun 30, 16	+4328.4%

TTM Net Income History

Month	Value	Change
Sep 2026	$6.48B	-8.5%
Jun 2026	$7.08B	-17.1%
Mar 2026	$8.53B	+3.0%
Dec 2025	$8.29B	+4.1%
Sep 2025	$7.96B	+54.4%
Jun 2025	$5.16B	+12.0%
Mar 2025	$4.60B	+23.0%
Dec 2024	$3.74B	+4.1%
Sep 2024	$3.59B	-34.1%
Jun 2024	$5.45B	-9.0%
Mar 2024	$5.99B	-9.3%
Dec 2023	$6.60B	-17.6%
Sep 2023	$8.01B	+14.7%
Jun 2023	$6.99B	+21.8%
Mar 2023	$5.74B	-6.4%
Dec 2022	$6.13B	+28.0%
Sep 2022	$4.79B	-7.5%
Jun 2022	$5.18B	-14.0%
Mar 2022	$6.02B	+11.8%
Dec 2021	$5.38B	-9.1%
Sep 2021	$5.93B	-8.4%
Jun 2021	$6.47B	-16.2%
Mar 2021	$7.72B	-5.0%
Dec 2020	$8.13B	-9.4%
Sep 2020	$8.97B	-2.9%
Jun 2020	$9.24B	+22.2%
Mar 2020	$7.56B	+12.9%
Dec 2019	$6.70B	+4.4%
Sep 2019	$6.42B	+2.3%
Jun 2019	$6.28B	+12.6%
Mar 2019	$5.57B	+4.2%
Dec 2018	$5.34B	+67.5%
Sep 2018	$3.19B	+4.8%
Jun 2018	$3.05B	+33.0%
Mar 2018	$2.29B	-16.7%
Dec 2017	$2.75B	-24.1%
Sep 2017	$3.62B	+22.4%
Jun 2017	$2.96B	+24.8%
Mar 2017	$2.37B	+75.1%
Dec 2016	$1.35B	+333.0%
Sep 2016	$312.54M	+113.7%
Jun 2016	$146.23M	-85.7%
Mar 2016	$1.02B	-91.9%
Dec 2015	$12.67B	-15.2%
Sep 2015	$14.94B	+2.4%
Jun 2015	$14.58B	-6.5%
Mar 2015	$15.59B	+235.8%
Dec 2014	$4.64B	-34.7%
Sep 2014	$7.11B	-11.5%
Jun 2014	$8.04B	-5.6%
Mar 2014	$8.52B	-4.5%
Dec 2013	$8.92B	+45.1%
Sep 2013	$6.15B	-4.6%
Jun 2013	$6.44B	-5.8%
Mar 2013	$6.84B	-7.6%
Dec 2012	$7.40B	-8.7%
Sep 2012	$8.11B	-5.4%
Jun 2012	$8.57B	+2.3%
Mar 2012	$8.38B	-4.3%
Dec 2011	$8.76B	+52.8%
Sep 2011	$5.73B	+4.1%
Jun 2011	$5.51B	+68.9%
Mar 2011	$3.26B	+13.2%
Dec 2010	$2.88B	-56.4%
Sep 2010	$6.60B	-2.3%
Jun 2010	$6.76B	-28.4%
Mar 2010	$9.44B	+5.4%
Dec 2009	$8.96B	+15.0%
Sep 2009	$7.79B	+3.8%
Jun 2009	$7.51B	-3.6%
Mar 2009	$7.79B	-11.1%
Dec 2008	$8.76B	-6.8%
Sep 2008	$9.41B	-7.4%
Jun 2008	$10.16B	-1.0%
Mar 2008	$10.26B	-3.3%
Dec 2007	$10.61B	-1.0%
Sep 2007	$10.72B	+0.4%
Jun 2007	$10.67B	+2.4%
Mar 2007	$10.42B	+3.1%
Dec 2006	$10.11B	+3.0%
Sep 2006	$9.81B	+4.7%
Jun 2006	$9.37B	+2.6%

Month	Value	Change
Mar 2006	$9.13B	+4.2%
Dec 2005	$8.76B	+6.3%
Sep 2005	$8.25B	+4.3%
Jun 2005	$7.90B	+2.5%
Mar 2005	$7.71B	+4.9%
Dec 2004	$7.35B	+1.4%
Sep 2004	$7.24B	-0.6%
Jun 2004	$7.29B	-2.4%
Mar 2004	$7.47B	-0.1%
Dec 2003	$7.47B	-1.8%
Sep 2003	$7.61B	+9.6%
Jun 2003	$6.94B	+6.7%
Mar 2003	$6.51B	+7.5%
Dec 2002	$6.05B	+1.1%
Sep 2002	$5.99B	+13.1%
Jun 2002	$5.29B	+5.3%
Mar 2002	$5.03B	+9.6%
Dec 2001	$4.59B	-18.8%
Sep 2001	$5.65B	-8.5%
Jun 2001	$6.18B	+2.4%
Mar 2001	$6.03B	-3.5%
Dec 2000	$6.25B	+39.6%
Sep 2000	$4.47B	+9.0%
Jun 2000	$4.10B	+16.4%
Mar 2000	$3.53B	+17.6%
Dec 1999	$3.00B	-3.2%
Sep 1999	$3.10B	-3.1%
Jun 1999	$3.20B	+2.8%
Mar 1999	$3.11B	+2.2%
Dec 1998	$3.04B	+7.6%
Sep 1998	$2.83B	+5.8%
Jun 1998	$2.67B	-5.4%
Mar 1998	$2.83B	-5.6%
Dec 1997	$3.00B	-20.1%
Sep 1997	$3.75B	+15.3%
Jun 1997	$3.25B	+1.3%
Mar 1997	$3.21B	+1.2%
Dec 1996	$3.17B	+77.5%
Sep 1996	$1.79B	-11.4%
Jun 1996	$2.02B	+21.9%
Mar 1996	$1.65B	-0.8%
Sep 1995	$1.67B	+0.3%
Jun 1995	$1.66B	+2.0%
Mar 1995	$1.63B	-3.9%
Dec 1994	$1.70B	-6.5%
Sep 1994	$1.81B	-6.5%
Jun 1994	$1.94B	+0.4%
Mar 1994	$1.93B	-2.8%
Dec 1993	$1.99B	+4.0%
Sep 1993	$1.91B	+3.0%
Jun 1993	$1.86B	+3.1%
Mar 1993	$1.80B	+1.5%
Dec 1992	$1.77B	-0.2%
Sep 1992	$1.78B	+0.2%
Jun 1992	$1.77B	-7.9%
Mar 1992	$1.93B	+5.1%
Dec 1991	$1.83B	+5.3%
Sep 1991	$1.74B	+6.4%
Jun 1991	$1.63B	+10.3%
Mar 1991	$1.48B	+3.0%
Dec 1990	$1.44B	+3.2%
Sep 1990	$1.40B	+3.0%
Jun 1990	$1.35B	+0.2%
Mar 1990	$1.35B	+8.6%
Dec 1989	$1.25B	+3.7%
Sep 1989	$1.20B	+3.4%
Jun 1989	$1.16B	+0.5%
Mar 1989	$1.16B	+2.6%
Dec 1988	$1.13B	+4.3%
Sep 1988	$1.08B	+3.5%
Jun 1988	$1.04B	+10.2%
Mar 1988	$947.03M	+1.4%
Dec 1987	$933.59M	+7.6%
Sep 1987	$868.04M	+8.6%
Jun 1987	$799.51M	+14.0%
Mar 1987	$701.22M	+9.6%
Dec 1986	$639.66M	+3.1%
Sep 1986	$620.56M	+5.5%
Jun 1986	$588.32M	+28.8%
Mar 1986	$456.77M	+49.8%
Dec 1985	$304.93M	+101.4%
Sep 1985	$151.39M	-

FAQ

What is the current TTM net income of GSK?: As of today, GSK TTM net income is $6.48B
What is GSK TTM net income most recent change?: GSK TTM net income was down -8.51% on September 30, 2026
What is 1-year change in GSK TTM net income?: GSK TTM net income is down -18.67% year-over-year
How far is GSK TTM net income from its all-time high?: GSK TTM net income is currently -58.46% below its historical high of $15.59B set on March 31, 2015
How does GSK TTM net income rank versus sector peers?: GSK TTM net income is higher than 98.87% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Net Income Formula

Net Income = Revenue − Cost Of Goods Sold − Operating Expenses − Interest Expense − Income Tax − Other Expenses

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk